JNJ Stock Analysis: Buy, Sell, or Hold?
JNJ - Johnson & Johnson
$226.71
-4.09 (-1.77%)
▼
5d:
+2.44%
30d:
-3.34%
90d:
-6.88%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Jul 15, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.3/10
Get Alerted When JNJ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called JNJ this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: JNJ shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: JNJ shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$327.96
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$203.64
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JNJ is currently trading at $226.71, which is considered slightly low relative to its 30-day fair value range of $224.22 to $236.87. The stock's valuation (Forward PE: 17.8) is in line with its historical norms (18.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, JNJ is in a strong uptrend. The price is currently testing key support at $220.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JNJ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $252.42 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, JNJ is in a strong uptrend. The price is currently testing key support at $220.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JNJ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $252.42 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$224.22 -
$236.87
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($252.42)
Trading Range Analysis
30-Day Trading Range
$224.22 -
$236.87
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$220.37
Resistance Level
$232.14
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.84
Wall Street Target
$252.42
(+11.3%)
Revenue Growth (YoY)
9.9%
Earnings Growth (YoY)
-52.9%
Profit Margin
21.8%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
17.8 vs 18.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$223.99
(-1%)
2-Year Target
$221.30
(-2%)
3-Year Target
$218.65
(-4%)
3-Yr Target (if PE normalizes)
(PE: 18→19)
$226.78
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 9.8%)
$371.40
(+64%)
Base:
(SPY PE: 17.8, Growth: 9.8%)
$300.16
(+32%)
Bear:
(PE: 15.2, Growth: 9.8%)
$255.14
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 26.74 | Current EPS (TTM): $8.63
Bull Case
$373.92
(+65%)
Analyst growth 47.3%, PE expands to 29.4
Base Case
$339.93
(+50%)
Market implied 47.3%, PE stable at 26.7
Bear Case
$156.94
(-31%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.8 to 18.5
Stabilization Target:
$235.14
(+3.7%)
PE Expansion Potential:
+3.7%
Share & Embed Analysis
Last updated: May 18, 2026 9:44 AM ET
Data refreshes hourly during market hours. Next update: 10:44 AM
Data refreshes hourly during market hours. Next update: 10:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JNJ showing a specific setup today?
Insider Activity (6 Months)
3
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Thomas H. Kean, Jr.
SELL
2026-03-26
John Boozman
SELL
2026-03-19
Richard McCormick
SELL
2026-03-19
Featured in Portfolios
JNJ is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1210 | 62 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 61 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$253 | 65 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$218 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 60 HOLD |
Advanced JNJ Option Strategies
Professional options setups generated by AI based on today's JNJ price and gamma walls.
